Bolorforosh Said 4
4 · HAEMONETICS CORP · Filed Jun 13, 2018
Insider Transaction Report
Form 4
Bolorforosh Said
EVP, Chief Technology Officer
Transactions
- Award
Non-qualified Stock Option (Right to Buy)
2018-06-11+3,330→ 3,330 totalExercise: $93.52Exp: 2025-06-11→ Common Stock (3,330 underlying) - Award
Common Stock
2018-06-11+935→ 935 total
Footnotes (3)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.